You have 9 free searches left this month | for more free features.

Mismatched

Showing 1 - 25 of 497

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

Recruiting
  • Hematologic Malignancy
  • Stem Cell Transplant Complications
  • Beijing protocol
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Jun 19, 2023

MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

Recruiting
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia
  • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
  • Standard of Care Chemotherapy
  • Tampa, Florida
    Moffitt Cancer Center
Sep 27, 2022

Patients Receiving Mismatched Allogeneic HCT Trial in Germany (immunosuppression)

Terminated
  • Patients Receiving Mismatched Allogeneic HCT
  • Mainz, Germany
  • +3 more
Jun 29, 2022

Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

Recruiting
  • Sickle Cell Disease
  • Bone Marrow Transplant (BMT)
  • +7 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Sep 13, 2022

Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)

Not yet recruiting
  • Kidney Transplant Rejection
  • MDR-102
  • Immunosuppressive Agents
  • (no location specified)
Apr 4, 2022

Acute Myeloid Leukemia, MDS Trial in Marseille (HLA-mismatched microtransplantation)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • HLA-mismatched microtransplantation
  • Marseille, Bouches Du Rhône, France
    Institut Paoli Calmettes
Oct 11, 2021

Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

Completed
  • Multiple Myeloma
  • +7 more
  • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,

Not yet recruiting
  • End Stage Kidney Disease
  • +3 more
  • Donor CD34+, CD3+. and belumosudil
  • Los Angeles, California
    University of California, Los Angeles
Apr 6, 2023

AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)

Recruiting
  • AML - Acute Myeloid Leukemia
  • +5 more
  • T-allo10
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

Blood Transfusion Trial in Canada (Red blood cells)

Active, not recruiting
  • Blood Transfusion
  • Red blood cells
  • Hamilton, Ontario, Canada
  • +4 more
May 30, 2022

Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)

Recruiting
  • Hematologic Malignancies
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)

Recruiting
  • Transplant-Related Hematologic Malignancy
  • Atlanta, Georgia
    Northside Hospital
Oct 19, 2022

Sickle Cell Disease Trial in Saint Louis (drug, radiation, procedure)

Terminated
  • Sickle Cell Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 28, 2022

Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,

Recruiting
  • Severe Sickle Cell Disease
  • +5 more
  • RIC regimen
  • GVHD prophylaxis regimen
  • New Haven, Connecticut
  • +1 more
Feb 4, 2022

Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)

Completed
  • Severe Aplastic Anemia
  • Bone Marrow Failure Syndromes
  • Bone marrow transplant
  • +7 more
  • Baltimore, Maryland
  • +1 more
Feb 10, 2022

Solid Tumor Trial in Beijing (KN035)

Recruiting
  • Solid Tumor
  • KN035
  • Beijing, Beijing, China
    Peking University Cancer Hospital, Peking University
Apr 5, 2022

Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

Active, not recruiting
  • Acute Lymphoid Leukemia (ALL)
  • +5 more
  • Hyperfractionated total body irradiation
  • +9 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

Not yet recruiting
  • Leukemia, Acute
  • +7 more
  • (no location specified)
Apr 10, 2023

Colorectal Carcinoma Trial (Pembrolizumab)

Completed
  • Colorectal Carcinoma
  • Pembrolizumab
  • (no location specified)
Mar 29, 2022

Myeloid Malignancies Trial in Italy (GvHD prophylaxis)

Recruiting
  • Myeloid Malignancies
  • GvHD prophylaxis
  • Alessandria, Italy
  • +32 more
Nov 23, 2022

Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

Suspended
  • Hematologic Malignancies
  • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
  • La Jolla, California
    UCSD Medical Center
Jul 20, 2022

Acute Leukemia, MDS Trial in Chicago (device, drug, other)

Recruiting
  • Acute Leukemia
  • MDS
  • Arm1
  • Arm 1
  • Chicago, Illinois
    University of Illinois Cancer Center
Oct 13, 2022

Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

Recruiting
  • Myeloid Malignancies
  • +3 more
  • Houston, Texas
    M D Anderson Caner Center
Nov 17, 2022